| Literature DB >> 27957667 |
Marcia Cruz-Correa1,2, Julyann Pérez-Mayoral3,4, Julie Dutil5, Miguel Echenique6, Rafael Mosquera7, Keila Rivera-Román8, Sharee Umpierre3, Segundo Rodriguez-Quilichini3, Maria Gonzalez-Pons3,4, Myrta I Olivera3,4, Sherly Pardo9.
Abstract
The three major hereditary cancer syndromes in Latinos (Hereditary Breast and Ovarian Cancer, Familial Adenomatous Polyposis and Lynch Syndrome) have been shown to exhibit geographic disparities by country of origin suggesting admixture-based disparities. A solid infrastructure of clinical genetics geared towards diagnosis and prevention could aid in reducing the mortality of these cancer syndromes in Latinos. Currently, clinical cancer genetic services in Latin America are scarce. Moreover, limited studies have investigated the mutational spectrum of these cancer syndromes in Latinos resulting in gaps in personalized medicine affecting diagnosis, treatment and prevention. The following commentary discusses available genotype and clinical information on hereditary cancer in Latinos and highlights the limited access for cancer genetic services in Latin America including barriers to genetic testing and alternatives for providing better access to genetic services. In this review, we discuss the status of clinical genetic cancer services for both US Latinos and those Latinos living in Latin America.Entities:
Keywords: Genetic counseling; Genetic testing; Health disparities; Hereditary cancer; Hispanics
Mesh:
Year: 2016 PMID: 27957667 PMCID: PMC5418082 DOI: 10.1007/s10897-016-0051-x
Source DB: PubMed Journal: J Genet Couns ISSN: 1059-7700 Impact factor: 2.537